Retatrutide, a GIP/GLP-1/Glucagon receptor agonist (GGG tri-agonist) in development by Eli Lilly and Company, isnt on the market yet
metformina) nie przynosz oczekiwanego efektu
We also dive into:How to push back on diet culture without vilifying the foods you actually enjoy (yes, you can like both brownies and dates).How to talk about diet culture without losing your mind.How medical test results can look different for athletes and why context matters.The eternal debate: fuel by distance, time, or effort?Along the way, we share taper madness energy, Run Rabbit hype, inflatable unicorns, Aussie shepherd nationals, and our complicated feelings about cottage cheese.This ones equal parts science, sass, and honestythe perfect YDS mix
Brand-name stability testing Novo Nordisk, the manufacturer of Ozempic and Wegovy, conducts extensive stability studies as part of the FDA approval process
Hypoxic in vitro culture reduces histone lactylation and impairs pre-implantation embryonic development in mice